2022 annual financial data
Novavax 2022 Revenue growth
Direct answer
Revenue growth was 39.49%.
Operating income was -644,736,000 USD and net income was -657,939,000 USD.
Operating cash flow was -415,937,000 USD.
Get free Novavax email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,598,951,000 USD
- Operating income
- -644,736,000 USD
- Net income
- -657,939,000 USD
- Operating cash flow
- -415,937,000 USD